Dual effect of methylprednsolone pulses on apoptosis of peripheral leukocytes in patients with renal diseases

International Journal of Immunopathology and Pharmacology

Volumn 19, Issue 3, 2006, Pages 647-659

  Stratta, Piero ^a   Canavese, C ^a   Fenoglio, R ^b   Priolo, G ^c   Grillo, A ^c   Aimo, G ^c   Quaglia, M ^a   Pagni, R ^c  

^a UNIVERSITY OF EASTERN PIEDMONT   (Italy)

^b UNIVERSITY OF TURIN   (Italy)

^c MOLINETTE HOSPITAL   (Italy)

Author keywords

Apoptosis; Lymphocyte subsets; Membranous glomerulonephritis; Primary glomerulonephritis; Steroid; Systemic Lupus Erythematosus; Vasculitis

Indexed keywords

DNA FRAGMENT; METHYLPREDNISOLONE; PREDNISONE;

ADULT; APOPTOSIS; ARTICLE; CD8+ T LYMPHOCYTE; CELL COUNT; CIRCADIAN RHYTHM; CONTROLLED STUDY; DIALYSIS; DRUG EFFECT; DRUG PULSE THERAPY; FEMALE; HUMAN; IN VIVO STUDY; INTERSTITIAL NEPHRITIS; KIDNEY DISEASE; LEUKOCYTE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL;

EID: 33750068620     PISSN: 03946320     EISSN: None     Source Type: Journal    
DOI: 10.1177/039463200601900321     Document Type: Article

References (44)

1. Kroll J. 2004. The molecular chaperones and the phenomena of cellular immortalization and apoptosis in vitro. Ann. N.Y. Acad. Sci. 1019:568.
2. Cline A.M. and M.Z. Radic. 2004. Apoptosis, subcellular particles, and autoimmunity. Clin. Immunol. 112:175.
3. Shi Y. 2004. Caspase activation: revisiting the induced proximity model. Cell 117:855.
4. Rose L.M., D.S. Latchman and D.A. Isenberg. 1997. Apoptosis in peripheral lymphocytes in Systemic Lupus erythematosus: a review. Br. J. Rheumatol. 36:158.
5. Stewart S.A., B. Poon, J.Y. Song and I.S. Chen. 2000. Human immunodeficiency virus type 1 vpr induces apoptosis through caspase activation. J. Virol 74:3105.
6. de Vries E.G., T. Timmer, N.H. Mulder, C.M. van Geelen, W.T. van der Graaf, D.C. Spierings, M.N. de Hooge, J.A. Gietema and S. de Jong. 2003. Modulation of death receptor pathways in oncology. Drugs Today (Barc) 39(S):95.
7. Otake Y., T.K. Sengupta, S. Bandyopadhyay, E.K. Spicer and D.J. Fernandes. 2004. Drug-induced destabilization of bcl-2 mRNA: a new approach for inducing apoptosis in tumor cells. Curr. Opin. Investig. Drugs. 5:616.
8. Renner K., M.J. Ausserlechner and R. Kofler. 2003. A conceptual view on glucocorticoid-induced apoptosis, cell cycle arrest and glucocorticoid resistance in lymphoblastic leukemia. Curr. Mol. Med. 3:707.
9. Heasman S.J., K.M. Giles, C. Ward, A.G. Rossi, C. Haslett and I. Dransfield. 2003. Glucocorticoid-mediated regulation of granulocyte apoptosis and macrophage phagocytosis of apoptotic cells: implications for the resolution of inflammation. J. Endocrinol. 178:29.
10. Distelhorst C.W. 2002. Recent insights into the mechanism of glucocorticosteroid-induced apoptosis. Cell Death Differ. 9:6.
11. Manabe T. 2000. Combination of electrophoretic techniques for comprehensive analysis of complex protein systems. Electrophoresis 21:1116.
12. Cohen J.J., R.C. Duke, R. Chervenak, K.S. Sellins and L.K. Olson. 1985. DNA fragmentation in targets of CTL: an example of programmed cell death in the immune system. Adv. Exp. Med. Biol. 184:493.
13. Fukuda R., T. Horiki, T. Sasao, H. Kawada and Y. Ichikawa. 1996. Modulation of peripheral blood lymphocyte subsets during methylprednisolone pulse therapy. Tokai J. Exp. Clin. Med. 21:77.
14. Takahashi S., L. Fossati, M. Iwamoto, R. Merino, R. Motta, T. Kobayakawa and S. Izui. 1996. Imbalance towards Th1 predominance is associated with acceleration of lupus-like autoimmune syndrome in MRL mice. Clin. Invest. 97:1597.
15. Savill J., A. Mooney and J. Hughes. 1996. What role does apoptosis play in progression of renal disease? Curr. Opin. Nephrol. Hypertens. 5:369.
16. Sugiyama H., N. Kashihara, H. Makino, Y. Yamasaki and A. Ota. 1996. Apoptosis in glomerular sclerosis. Kidney Int. 49:103.
17. Lan H.Y., H. Mitsuhashi, Y.Y. Ng, D.J. Nikolic-Paterson, N. Yang, W. Mu and R.C. Atkins. 1997. Macrophage apoptosis in rat crescentic glomerulonephritis. Am. J. Pathol 151:531.
18. Takemura T., K. Murakami, H. Miyazato, K. Yagi and K. Yoshioka 1995. Expression of Fas antigen and Bcl-2 in human glomerulonephritis. Kidney Int. 48:1886.
19. Berden J.H. 2003. Lupus nephritis: consequence of disturbed removal of apoptotic cells? Neth. J. Med. 61:233.
20. Trebeden-Negre H., B. Weill, C. Fournier and F. Batteux. 2003. B cell apoptosis accelerates the onset of murine lupus. Eur. J. Immunol. 33(6):1603.
21. Makino H., H. Sugiyama, Y. Yamasaki, Y. Maeshima, J. Wada and N. Kashihara. 2003. Glomerular cell apoptosis in human lupus nephritis. Virchows Arch. 443:67.
22. Marquina R., M.A. Diez, M. Lopez-Hoyos, L. Buelta, A. Kuroki, S. Kikuchi, J. Villegas, M. Pihlgren, C.A. Siegrist, M. Arias, S. Izui, J. Merino and R. Merino. 2004. Inhibition of B cell death causes the development of an IgA nephropathy in (New Zealand white × C57BL/6)F(1)-bcl-2 transgenic mice. J. Immunol. 172:7177.
23. Amore A., P. Cirina, G. Conti, P. Brusa, L. Peruzzi and R. Coppo. 2001. Glycosylation of circulating IgA in patients with IgA nephropathy modulates proliferation and apoptosis of mesangial cells. J. Am. Soc. Nephrol. 12:1862.
24. Baba K., S. Minatoguchi, H. Sano, T. Kagawa, I. Murata, G. Takemura, T. Hirano, H. Ohashi, M. Takemura, T. Fujiwara and H. Fujiwara. 2004. Involvement of apoptosis in patients with diabetic nephropathy: A study on plasma soluble Fas levels and pathological findings. Nephrology (Canton) 9:94.
25. Ecder T., V.Y. Melnikov, M. Stanley, D. Korular, M.S. Lucia, R.W. Schrier and C.L. Edelstein. 2002. Caspases, Bcl-2 proteins and apoptosis in autosomal-dominant polycystic kidney disease. Kidney Int. 61:1220.
26. Rodgers K.D., V. Rao, D.T. Meehan, N. Fager, P. Gotwals, S.T. Ryan, V. Koteliansky, R. Nemori and D. Cosgrove. 2003. Monocytes may promote myofibroblast accumulation and apoptosis in Alport renal fibrosis. Kidney Int. 63:1338.
27. Savin M., V. Bumbasirevic, L. Djukanovic and V. Petronic. 2001.The significance of apoptosis for early diagnosis of Balkan nephropathy. Nephrol. Dial. Transplant. 16(S):30.
28. Bonegio R. and W. Lieberthal 2002. Role of apoptosis in the pathogenesis of acute renal failure. Curr. Opin. Nephrol. Hypertens. 11:301.
29. Karpman D., A. Hakansson, M.T. Perez, C. Isaksson, E. Carlemalm, A. Caprioli and C. Svanborg. 1998. Apoptosis of renal cortical cells in the hemolytic-uremic syndrome: in vivo and in vitro studies. Infect. Immun. 66:636.
30. Li C., S.W. Lim, B.K. Sun, B.S. Choi, G. Lowacka, A. Cox, D. Kelly, Y.S. Kim, J. Kim, B.K. Bang and C.W.S. Yang. 2004. Expression of apoptosis-related factors in chronic cyclosporine nephrotoxicity after cyclosporine withdrawal. Acta Pharmacol. Sin. 25:401.
31. Zhang G., S.D. Oldroyd, L.H. Huang, B. Yang, Y. Li, R. Ye and A.M. El Nahas. 2001. Role of apoptosis and Bcl-2/Bax in the development of tubulointerstitial fibrosis during experimental obstructive nephropathy. Exp. Nephrol. 9:71.
32. Hiraoka J., K. Asano, H. Sano, K. Fujisawa, M. Ohno, G. Takemura, S. Minatoguchi, H. Ohashi, T. Fujiwara and H. Fujiwara. 1998. Participation of apoptosis in renal amyloidosis. Nippon Jinzo Gakkai Shi. 40:276.
33. Kato S., Y. Akasaka and S. Kawamura. 1997. Fas antigen expression and its relationship with apoptosis in transplanted kidney. Pathol. Int. 47:230.
34. Wang W., A. Tzanidis, M. Divjak, N.M. Thomson and A.N. Stein-Oakley. 2001. Altered signaling and regulatory mechanisms of apoptosis in focal and segmental glomerulosclerosis. J. Am. Soc. Nephrol. 12:1422.
35. Scheltema J.M., J.C. Romijn, G.J. van Steenbrugge, F.H. Schroder and G.H. Mickisch. 2001. Inhibition of apoptotic proteins causes multidrug resistance in renal carcinoma cells. Anticancer Res. 21:3161.
36. Rincon J., M. Romero, N. Viera, A. Pedreanez and J. Mosquera. 2004. Increased oxidative stress and apoptosis in acute puromycin aminonucleoside nephrosis. Int. J. Exp. Pathol. 85:25.
37. Yang B., T.S. Johnson, G.L. Thomas, P.F. Watson, B. Wagner and A.M. Nahas. 2001. Apoptosis and caspase-3 in experimental anti-glomerular basement membrane nephritis. J. Am. Soc. Nephrol. 12:485.
38. Sugiyama H., N. Kashihara, T. Onbe, Y. Yamasaki, J. Wada, T. Sekikawa, K. Okamoto, K. Kanao, Y. Maeshima and H. Makino. 1997. Bcl-2 expression and apoptosis in nephrotoxic nephritis. Exp. Nephrol. 5:481.
39. Kotnik V., A. Premzl, M. Skoberne, T. Malovrh, R. Kveder, S. Kaplan-Pavlovcic, A. Kotnik and D. Stiblar-Martincic. 2003. Demonstration of apoptosis-associated cleavage products of DNA, complement activation products SC5b-9 and C3d/dg, and immune complexes CIC-C3d, CIC-IgA, and CIC-IgG in the urine of patients with membranous glomerulonephritis. Croat. Med. J. 44:707.
40. Ozaki T., Y. Tomino, S. Nakayama and H. Koide. 1992. Two-color analysis of lymphocyte subpopulations in patients with nephrotic syndrome due to membranous nephropathy. Clin. Nephrol. 38:75.
41. Dimri R., Y. Sharabi and J. Shoham. 2000. Specific inhibition of glucocorticoid-induced thymocyte apoptosis by substance P. J. Immunol. 164:2479.
42. Bertouch J.V., P.J. Roberts-Thomson and J. Bradley. 1983. Diurnal variation of lymphocyte subsets identified by monoclonal antibodies. Br. Med. J. (Clin. Res. Ed.) 286:1171.
43. Leussink V.I., S. Jung, U. Merschdorf, K.V. Toyka and R. Gold. 2001. High-dose methylprednisolone therapy in multiple sclerosis induces apoptosis in peripheral blood leukocytes. Arch. Neurol. 58:91.
44. Stratta P., C. Canavese, S. Ferrero and A. Vercellone. 1992. T-lymphocyte subsets and platelet count (PLT) in lupus (SLE) patients treated by intravenous pulse cyclophosphamide (IVCP). Abs: XXIX Congress of EDTA, Paris p. 60.